ADVANCED CHOLANGIOCARCINOMA
Clinical trials for ADVANCED CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to tame rare bile duct cancer
Disease control Recruiting nowThis study tests whether combining three drugs (pemigatinib, atezolizumab, and bevacizumab) can help control advanced bile duct cancer that has a specific genetic change (FGFR2 fusion). About 25 adults whose cancer has not responded to other treatments will participate. The goal …
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 10:44 UTC
-
New hope for bile duct cancer: targeted drug shows promise in phase 2 trial
Disease control Recruiting nowThis study tests two different doses (20 mg and 16 mg) of the drug futibatinib in people with advanced bile duct cancer that has a specific genetic change (FGFR2 fusion or rearrangement). About 120 participants who have already received chemotherapy will take the drug daily to se…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated May 17, 2026 10:38 UTC
-
New drug AU409 enters first human tests for tough liver cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called AU409 in people with advanced liver cancer or other cancers that have spread to the liver. The main goals are to find the safest dose and see what side effects occur. About 36 adults whose cancer has not responded to standard treatme…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Cancer care at home: a game changer for patients?
Symptom relief Recruiting nowThis study compares giving cancer treatment at home versus in a clinic for people with advanced cancers. The goal is to see if home treatment reduces stress, financial burden, and improves the overall experience. About 220 participants will be randomly assigned to receive their t…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC